SCHEMBL30397969

SCHEMBL30397969

Nc1ccccc1S(=O)(=O)N1CCOCC1

nearest known ligand 0.55

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
POLB P06746 3/20 0.53
KMT2A Q03164 3/20 0.53
MEN1 O00255 1/20 0.53
GAA P10253 1/20 0.53
L3MBTL1 Q9Y468 2/20 0.52
ALOX5AP P20292 3/20 0.52
FEN1 P39748 3/20 0.52
NPC1 O15118 1/20 0.51
USP2 O75604 1/20 0.51
GCK P35557 1/20 0.51
SMN1; SMN2 Q16637 3/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
TSHR P16473 1/20 0.50
CYP2C19 P33261 1/20 0.50
ATM Q13315 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
ALDH1A1 P00352 1/20 0.49
LMNA P02545 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2062548 1.00 POLB (0.53) POLBKMT2AMEN1GAAL3MBTL1
SCHEMBL13788913 0.84 KMT2A (0.63) POLBKMT2AMEN1GAAL3MBTL1
SCHEMBL13206961 0.84 L3MBTL1 (0.51) POLBKMT2AMEN1GAAL3MBTL1
SCHEMBL5342056 0.84 TSHR (0.71) KMT2AMEN1GAAALOX5APFEN1
SCHEMBL8140330 0.82 TSHR (0.75) KMT2AMEN1GAAL3MBTL1ALOX5AP
SCHEMBL1439966 0.82 TSHR (0.75) KMT2AMEN1GAAL3MBTL1ALOX5AP
SCHEMBL3247291 0.81 CNR1 (0.56) POLBKMT2AMEN1GAAL3MBTL1
SCHEMBL10037158 0.79 USP2 (0.51) KMT2AMEN1GAAALOX5APFEN1
SCHEMBL3343329 0.79 PKM (0.58) POLBKMT2AMEN1GAAL3MBTL1
SCHEMBL20627051 0.79 POLB (0.53) POLBKMT2AMEN1GAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4716529-A2 COMPOUNDS THAT RE-ACTIVATE MUTANT P53 Institute For Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center (US) 2026-04-01 EP disclosed
WO-2024243343-A2 COMPOUNDS THAT RE-ACTIVATE MUTANT P53 KARANICOLAS JOHN (US) 2024-11-28 WO disclosed
CN-116059196-A Compounds and methods for inducing cartilage formation 斯克利普斯研究所 2023-05-05 CN disclosed